Search Results - "Raju, Kanumuri S"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Antileishmanial Activity of Pyrazolopyridine Derivatives and Their Potential as an Adjunct Therapy with Miltefosine by Anand, Devireddy, Yadav, Pawan Kumar, Patel, Om P. S, Parmar, Naveen, Maurya, Rahul K, Vishwakarma, Preeti, Raju, Kanumuri S. R, Taneja, Isha, Wahajuddin, M, Kar, Susanta, Yadav, Prem P

    Published in Journal of medicinal chemistry (09-02-2017)
    “…A series of pyrazolo­(dihydro)­pyridines was synthesized and evaluated for antileishmanial efficacy against experimental visceral leishmaniasis (VL). Among all…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Investigation of the Functional Role of P-Glycoprotein in Limiting the Oral Bioavailability of Lumefantrine by WAHAJUDDIN, RAJU, Kanumuri S. R, SINGH, Sheelendra P, TANEJA, Isha

    Published in Antimicrobial Agents and Chemotherapy (01-01-2014)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  4. 4

    Intravenous pharmacokinetics, oral bioavailability, dose proportionality and in situ permeability of anti-malarial lumefantrine in rats by Wahajuddin, Singh, Sheelendra P, Raju, Kanumuri S R, Nafis, Asad, Puri, Sunil K, Jain, Girish K

    Published in Malaria journal (10-10-2011)
    “…Despite the wide spread use of lumefantrine, there is no study reporting the detailed preclinical pharmacokinetics of lumefantrine. For the development of…”
    Get full text
    Journal Article
  5. 5

    Synthesis and Antimalarial Activity of 3,3-Spiroanellated 5,6-Disubstituted 1,2,4-Trioxanes by Maurya, Ranjani, Soni, Awakash, Anand, Devireddy, Ravi, Makthala, Raju, Kanumuri S. R, Taneja, Isha, Naikade, Niraj K, Puri, S. K, Wahajuddin, Kanojiya, Sanjeev, Yadav, Prem P

    Published in ACS medicinal chemistry letters (14-02-2013)
    “…Novel 3,3-spiroanellated 5-aryl, 6-arylvinyl-substituted 1,2,4-trioxanes 19–34 have been synthesized and appraised for their antimalarial activity against…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Preclinical pharmacokinetic study of speciociliatine, a kratom alkaloid, in rats using an UPLC-MS/MS method by Berthold, Erin C., Kamble, Shyam H., Raju, Kanumuri S., King, Tamara I., Popa, Raluca, Sharma, Abhisheak, León, Francisco, Avery, Bonnie A., McMahon, Lance R., McCurdy, Christopher R.

    “…•Kratom is a Southeast Asian plant used in the United States for pain relief and mitigation of opioid withdrawal symptoms.•Speciociliatine in a minor indole…”
    Get full text
    Journal Article
  11. 11

    Bioanalytical method development and pharmacokinetics of MCI-92, a sigma-1 receptor ligand by Popa, Raluca, Kamble, Shyam H., Kanumuri, Raju S., King, Tamara I., Berthold, Erin C., Intagliata, Sebastiano, Sharma, Abhisheak, McCurdy, Christopher R.

    “…•A UPLC-MS/MS bioanalytical method for the quantification of MCI-92 was developed.•The method was validated in mouse plasma and brain following FDA…”
    Get full text
    Journal Article
  12. 12

    Simultaneous quantification of proposed anti-malarial combination comprising of lumefantrine and CDRI 97-78 in rat plasma using the HPLC-ESI-MS/MS method: application to drug interaction study by Wahajuddin, Muhammad, Singh, Sheelendra P, Taneja, Isha, Raju, Kanumuri S R, Gayen, Jiaur R, Siddiqui, Hefazat H, Singh, Shio K

    Published in Malaria journal (22-04-2015)
    “…Lumefantrine is the mainstay of anti-malarial combination therapy in most endemic countries presently. However, it cannot be used alone owing to its long onset…”
    Get full text
    Journal Article
  13. 13